Skip to main content

Table 4 The sensitivity and specificity of five gene expression levels for the prediction of irinotecan sensitivity

From: A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer

Genes

Chemotheraputic agents

Sensitivity

Specificity

AUC (95% CI)

P

APTX

Irinotecan

73%

74%

0.758 (0.669-0.847)

<0.001

BRCA1

Irinotecan

91%

58%

0.760 (0.673-0.846)

< 0.001

ERCC1

Irinotecan

64%

79%

0.726 (0.632-0.821)

<0.001

ISG15

Irinotecan

59%

73%

0.617 (0.494-0.740)

0.047

Topo1

Irinotecan

48%

94%

0.664 (0.563-0.765)

0.002